Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951

Journal of Clinical Oncology

Volumn 21, Issue 15, 2003, Pages 2940-2947

  Wells, Robert J ^a   Adams, Mary T ^b   Alonzo, Todd A ^b   Arceci, Robert J ^b   Buckley, Jonathan ^b   Buxton, Allen B ^b   Dusenbery, Kathryn ^b   Gamis, Alan ^b   Masterson, Margaret ^b   Vik, Terry ^b   Warkentin, Phyllis ^b   Whitlock, James A ^b  

^a CHILDREN S ONCOLOGY GROUP   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; CYTARABINE; ETOPOSIDE; MITOXANTRONE; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DRUG MEGADOSE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ADULT; CLINICAL TRIAL; DRUG ADMINISTRATION; FEMALE; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYTARABINE; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MITOXANTRONE; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0042386631     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.06.128     Document Type: Article

References (24)

1. Woods WG, Kobrinsky N, Buckley JD, et al: Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: A report from the Children's Cancer Group. Blood 87:4979-4989, 1996
2. Stevens RF, Hann IM, Wheatley K, et al: Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: Results of the United Kingdom Medical Research Council's 10th AML trial-MRC Childhood Leukaemia Working Party. Br J Haematol 101:130-140, 1998
3. Ravindranath Y, Yeager AM, Chang MN, et al: Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood: Pediatric Oncology Group. N Engl J Med 334:1428-1434, 1996
4. Creutzig U, Ritter J, Zimmermann M, et al: Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87. J Clin Oncol 11:279-286, 1993
5. Woods WG, Neudorf S, Gold S, et al: A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood 97:56-62, 2001
6. Dahl GV, Kalwinsky DK, Mirro J Jr, et al: Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 8:295-303, 1990
7. Nesbit ME Jr, Buckley JD, Feig SA, et al: Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: A report from the Children's Cancer Group. J Clin Oncol 12:127-135, 1994
8. Wells RJ, Woods WG, Buckley JD, et al: Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Children's Cancer Group Study. J Clin Oncol 12:2367-2377, 1994
9. Woods WG, Kobrinsky N, Buckley J, et al: Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Children's Cancer Group pilot study. J Clin Oncol 11:1448-1457, 1993
10. Yeager AM, Kaizer H, Santos GW, et al: Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315:141-147, 1986
11. Bosi A, Bacci S, Miniero R, et al: Second allogeneic bone marrow transplantation in acute leukemia: A multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO). Leukemia 11:420-424, 1997
12. Leahey A, Kelly K, Rorke LB, et al: A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML). J Pediatr Hematol Oncol 19:304-308, 1997
13. Santana VM, Mirro J Jr, Kearns C, et al: 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. J Clin Oncol 10:364-370, 1992
14. Wells RJ, Gold SH, Krill CE, et al: Cytosine arabinoside and mitoxantrone induction chemotherapy followed by bone marrow transplantation or chemotherapy for relapsed or refractory pediatric acute myeloid leukemia. Leukemia 8:1626-1630, 1994
15. Whitlock JA, Wells RJ, Hord JD, et al: High-dose cytosine arabinoside and etoposide: An effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia. Leukemia 11:185-189, 1997
16. Mann HB, Whitney DR: On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 18:50-60, 1947
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
18. Greenwood M: The natural duration of cancer, in: Reports on Public Health and Medical Subjects. London, England, His Majesty's Stationery Office, 33:1-26, 1926
19. Peto R, Peto J: Asymptotically efficient rank in variant test procedures. J R Stat Soc A 135:185-206, 1972
20. Cox DR: Regression models and life-tables. J R Stat Soc B 34:187-220, 1972
21. Hirji KF, Mehta CR, Patel NR: Computing distributions for exact logistic regression. J Am Stat Assoc 82:1110-1117, 1987
22. Barnard DR, Lange B, Alonzo TA, et al: Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: Comparison with primary presentation. Blood 100:427-434, 2002
23. Webb DK, Wheatley K, Harrison G, et al: Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial: MRC Childhood Leukaemia Working Party. Leukemia 13:25-31, 1999
24. Keating NJJ, Kantarjian H, Smith TS, et al: Response to salvage therapy and survival after relapse in acute myelogenous leukemia. J Clin Oncol 7:1071-1080, 1989